Stock Comparison
REGN vs RPRX
Regeneron Pharmaceuticals Inc and Royalty Pharma Plc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$66.35B
$32.38B
P/E (TTM)
15.5
29.6
Forward P/E
14.1
46.5
Price/Sales
4.5
13.3
Price/Book
2.1
3.6
EV/EBITDA
10.5
19.1
Dividend Yield
0.58%
1.64%
Profitability
Net Margin
29.60%
33.90%
Operating Margin
20.70%
100.30%
Return on Equity
14.50%
13.80%
Return on Assets
6.13%
5.54%
Growth (YoY)
Revenue Growth
19.00%
11.00%
Earnings Growth
-7.20%
23.20%
Price & Risk
Beta
0.2
0.4
52-Week High
$818.90
$56.50
52-Week Low
$516.07
$33.57
Analyst Target
$833.31
$59.25
Compare REGN and RPRX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.